DataMeds AI, Inc. (MEDS)
MEDS moved a median of -0.96% 30 minutes after news, and -2.03% by the close. How MEDS actually reacts to news — the realized, point-in-time move the market made, measured across 108 labeled events over the last three years with zero look-ahead.
MEDS’s median reaction, across the day.
| Horizon | Median | % positive | Events |
|---|---|---|---|
| 5-min | 0.00% | 37% | 52 |
| 30-min | -0.96% | 36% | 61 |
| 60-min | -0.88% | 37% | 65 |
| to close | -2.03% | 34% | 68 |
| Middle 50% of MEDS reactions | -5.45% to +1.28% |
|---|---|
| Median reaction (30-min) | -0.96% |
| Measured reactions | 108 |
Half of all DataMeds AI, Inc. news events land between -5.45% and +1.28% at 30 minutes.
Reaction stats as of 2026-09-21. Newest measured event . Reaction = percent move vs. the price at the news timestamp.
Email me when MEDS moves on news.
One email per qualifying move — the headline, the measured reaction, and how it compares to MEDS's baseline. Nothing else.
Recent MEDS events, each with its measured reaction.
| Date | Headline | Event | Source | 5-min | To close |
|---|---|---|---|---|---|
| DataMEDS AI Reports 50% Sequential Revenue Growth in Third Quarter 2026 From Second Quarter 2026, Delivers Net Profit Per Share of $2.72 and Provides Business Update | Press release | ACCESS Newswire | +20.30% | -12.06% | |
| Form 10-Q DataMeds AI, Inc. For: Sep 30 | SEC filing · Form 10-Q | SEC EDGAR | — | — | |
| Form 8-K DataMeds AI, Inc. For: Nov 13 | SEC filing · Form 8-K | SEC EDGAR | — | — | |
| Form S-1/A DataMeds AI, Inc. | SEC filing · Form S-1 | SEC EDGAR | +1.72% | +6.55% | |
| DataMEDS AI Announces Corexa Pharmacy's First Commercial Sale of Compounded Peptides Under FDA Enforcement Discretion Policy | Press release | ACCESS Newswire | -7.76% | -15.13% | |
| Form DEF 14C DataMeds AI, Inc. For: Nov 09 | SEC filing · Form DEF | SEC EDGAR | -0.96% | -13.82% | |
| DataMEDS AI Signs MOU to Deploy Health Lives Here GLP-1 Patient Management Program with Florida-Based HMO | Press release | ACCESS Newswire | +4.17% | -18.12% | |
| Form 8-K DataMeds AI, Inc. For: Nov 03 | SEC filing · Form 8-K | SEC EDGAR | +4.17% | -18.12% | |
| DataMEDS AI Announces Termination of Second Amended and Restated Letter of Intent | Press release | ACCESS Newswire | +1.16% | -13.37% | |
| DataMEDS AI Enters Into Agreement for Commercial Supply of Six Peptides Recommended by FDA Advisory Committee | Press release | ACCESS Newswire | +0.26% | -5.18% | |
| Form 8-K DataMeds AI, Inc. For: Oct 21 | SEC filing · Form 8-K | SEC EDGAR | -0.48% | +0.00% | |
| DataMEDS AI Establishes "Health Lives Here" Community Respiratory Program for Corexa Health Pharmacy Network | Press release | ACCESS Newswire | -1.39% | -5.51% | |
| DataMEDS AI Enters Into Amended and Restated LOI to License and Acquire IP that Enables Goal-Driven Prescription Drug Telehealth, Medical Drones and Healthcare Blockchain Technologies | Press release | ACCESS Newswire | -0.76% | -13.21% | |
| DataMeds Regains Compliance With NASDAQ Listing Standards | Press release | ACCESS Newswire | -0.76% | +4.96% | |
| Form 8-K DataMeds AI, Inc. For: Oct 19 | SEC filing · Form 8-K | SEC EDGAR | -0.76% | +4.96% | |
| DataMeds Applauds FDA's Proposed Interim Access Policy for Compounding Using Certain Peptides and Provides Corexa Health's Peptides Roadmap | Press release | ACCESS Newswire | +0.00% | -6.07% | |
| Form 8-K DataMeds AI, Inc. For: Oct 13 | SEC filing · Form 8-K | SEC EDGAR | -5.36% | -13.31% | |
| DataMEDS Si Licenses U.S. Rights To Reboot Health AI's Direct-To-Consumer GLP-1 Weight Management Platform | Press release | ACCESS Newswire | +0.17% | -3.23% | |
| DataMEDS SI Provides Business Update On CLIA Lab Helomics And Its Super Intelligence Predictive Oncology Division | Press release | ACCESS Newswire | +0.34% | +2.71% | |
| Form 8-K DataMeds AI, Inc. For: Oct 13 | SEC filing · Form 8-K | SEC EDGAR | -1.04% | -1.38% | |
| Form PRE 14C DataMeds AI, Inc. For: Oct 09 | SEC filing · Form PRE | SEC EDGAR | -1.05% | -1.91% | |
| DataMEDS SI Announces Helomics Receives Medicaid Coverage Policy For Chemofx(R) Assay In Gynecologic Cancers | Press release | ACCESS Newswire | +3.32% | -7.25% | |
| Form S-1/A DataMeds AI, Inc. | SEC filing · Form S-1 | SEC EDGAR | +3.32% | -7.25% | |
| Datameds AI Files DBAs Datameds SI And Corexa Health SI And Reminds Shareholders Of Record As Of August 7, 2026 Of Dream Bowl Meme Coin I Payment | Press release | ACCESS Newswire | -4.22% | -5.63% | |
| DataMeds AI's Corexa Pharmacy Surpasses $1 Million In Monthly Revenue | Press release | ACCESS Newswire | +2.16% | +3.31% | |
| DataMeds AI and Tollo Health Announce Launch of 'Health Lives Here' Mobile Application | Press release | ACCESS Newswire | -8.94% | -4.03% | |
| DataMEDS AI To Present At 2026 National Telehealth and Virtual Care Summit | Press release | ACCESS Newswire | -6.41% | -9.33% | |
| DataMEDS AI Unveils New Corporate Website | Press release | ACCESS Newswire | +2.16% | +0.24% | |
| DataMeds AI Litigation Settlement Extinguishes ~$19 million In Liabilities and Retires 364,099 Common Sharessked | Press release | ACCESS Newswire | -10.67% | -37.33% | |
| Form 8-K DataMeds AI, Inc. For: Sep 11 | SEC filing · Form 8-K | SEC EDGAR | -10.67% | -37.33% | |
| Form 8-K DataMeds AI, Inc. For: Sep 11 | SEC filing · Form 8-K | SEC EDGAR | -13.97% | -31.05% | |
| DataMEDS, AI. Acquires Helomics AI Cancer Diagnostics Lab and Precision Oncology CRO Businesses from Axe Compute | Press release | ACCESS Newswire | +6.89% | +49.51% | |
| Datameds, AI., and Tollo Health Partner with the NFL Alumni Association for Health Lives Here National Campaign Rollout | Press release | ACCESS Newswire | -1.67% | -4.83% | |
| Form PRE 14C DataMeds AI, Inc. For: Aug 31 | SEC filing · Form PRE | SEC EDGAR | +0.02% | +5.32% | |
| CORRECTION FROM SOURCE: DataMeds AI and Tollo Health Announce Fall 2026 Cold & Flu #Back2School50% Marketing Campaign for Viral Infections Medical Food Galectovid(TM) | Press release | ACCESS Newswire | — | — | |
| DataMeds AI and Tollo Health Announce Fall 2026 Cold & Flu #Back2School50% Marketing Campaign for Viral Infections Medical Food Galectovid(TM) | Press release | ACCESS Newswire | — | — | |
| Form 8-K DataMeds AI, Inc. For: Aug 17 | SEC filing · Form 8-K | SEC EDGAR | +0.00% | -4.83% | |
| DataMeds AI Reports Second Quarter 2026 Financials and Provides Business Update | Press release | ACCESS Newswire | -2.63% | -1.97% | |
| Form 10-Q DataMeds AI, Inc. For: Jun 30 | SEC filing · Form 10-Q | SEC EDGAR | -2.63% | -1.97% | |
| DataMEDS AI Announces Its Board of Directors Approved September 9, 2026 as the Payment Date of the Previously Announced Distribution of Dream Bowl Meme Coin I Tokens to Record Holders of Common Stock and other Eligible Equity Securities as of the Record D | Press release | ACCESS Newswire | -2.63% | -1.97% | |
| Form 8-K DataMeds AI, Inc. For: Aug 14 | SEC filing · Form 8-K | SEC EDGAR | -2.63% | -1.97% | |
| Form NT 10-Q DataMeds AI, Inc. For: Jun 30 | SEC filing · Form NT | SEC EDGAR | -2.63% | -1.97% | |
| DataMeds AI Provides Update on Corexa Health's Pharmacy Division | Press release | ACCESS Newswire | -2.11% | -6.34% | |
| DataMeds AI Renames Pharmacy Subsidiaries Corexa Pharmacy and Corexa Tech & Hub Under New Corexa Health Division | Press release | ACCESS Newswire | +3.46% | — | |
| Form S-1 DataMeds AI, Inc. | SEC filing · Form S-1 | SEC EDGAR | +3.46% | — | |
| DataMeds AI Reiterates 50:1 Dream Bowl Meme Coin Token to Common Shares Dividend Ratio with an August 7, 2026 Record Date | Press release | ACCESS Newswire | +4.00% | -4.00% | |
| DataMeds AI to be Featured In-Person on Fox Business' Claman Countdown to Introduce "Health Lives Here" | Press release | ACCESS Newswire | +4.33% | -13.31% | |
| Form 8-K DataMeds AI, Inc. For: Jul 29 | SEC filing · Form 8-K | SEC EDGAR | +4.33% | -13.31% | |
| DataMeds AI's Corexa Pharmacy Launches Tollo Health's Tollovid(R) and Galactovid(TM) | Press release | ACCESS Newswire | — | -4.13% | |
| DataMeds AI Expands License with DataVault AI for Data Driven Outcome Healthcare-focused Blockchain and Data Monetization License | Press release | ACCESS Newswire | -4.64% | -20.42% |
Each reaction is the move the market actually made, measured from the news timestamp. Headlines link through to the MEDS section they belong to.
Where else MEDS is measured.
MEDS earnings → · Analyst actions → · SEC filings →
Every ticker we measure the same way24
Apple (AAPL)
How AAPL actually reacts to news, measured.
NVIDIA (NVDA)
How NVDA actually reacts to news, measured.
Tesla (TSLA)
How TSLA actually reacts to news, measured.
Microsoft (MSFT)
How MSFT actually reacts to news, measured.
Advanced Micro Devices (AMD)
How AMD actually reacts to news, measured.
Amazon (AMZN)
How AMZN actually reacts to news, measured.
Alphabet (GOOG)
How GOOG actually reacts to news, measured.
Meta Platforms (META)
How META actually reacts to news, measured.
Broadcom (AVGO)
How AVGO actually reacts to news, measured.
JPMorgan Chase (JPM)
How JPM actually reacts to news, measured.
Visa (V)
How V actually reacts to news, measured.
Walmart (WMT)
How WMT actually reacts to news, measured.
Eli Lilly (LLY)
How LLY actually reacts to news, measured.
UnitedHealth Group (UNH)
How UNH actually reacts to news, measured.
Netflix (NFLX)
How NFLX actually reacts to news, measured.
Johnson & Johnson (JNJ)
How JNJ actually reacts to news, measured.
Exxon Mobil (XOM)
How XOM actually reacts to news, measured.
Home Depot (HD)
How HD actually reacts to news, measured.
Costco (COST)
How COST actually reacts to news, measured.
Mastercard (MA)
How MA actually reacts to news, measured.
Oracle (ORCL)
How ORCL actually reacts to news, measured.
Salesforce (CRM)
How CRM actually reacts to news, measured.
Bank of America (BAC)
How BAC actually reacts to news, measured.
Coca-Cola (KO)
How KO actually reacts to news, measured.
Walt Disney (DIS)
How DIS actually reacts to news, measured.
Browse all tickers
Every name we’ve measured, in one place.
How the numbers are made.
How is DataMeds AI, Inc.'s median reaction calculated?
Every labeled MEDS news event is measured from its own timestamp: the last trade before the news is the base price, and the move is read at fixed horizons — 30 minutes of trading, then the close. The median across 108 events is what this page reports. Point-in-time, zero look-ahead: no event borrows information from a later one.
What counts as a positive reaction?
Any event whose price move is above zero at the horizon, relative to the last trade before the news timestamp. 36% of MEDS's measured events are up at 30 minutes; the rest close the window flat or negative.
How often is this page updated?
The news table refreshes automatically as new events are labeled and priced. The reaction medians are re-pulled in batches from the dataset — the figures here are as of 2026-09-21.
Does MEDS's past reaction predict its next one?
No. These are realized facts about past events, not forecasts. They describe a distribution — they say nothing certain about any future move.